Medical Condition News

RSS

Community support critical for reducing childhood obesity

Community support of school obesity prevention programs is critical to achieving a significant decrease in obesity among children, according to researchers at the Michael & Susan Dell Center for Advancement of Healthy Living, which is part of The University of Texas Health Science Center at Houston (UTHealth).

4 Mar 2010

Scientists identify two proteins that serve as biomarkers for tracking the spread of colon cancer

Scientists in China are reporting discovery of two proteins present in the blood of people with colon cancer that may serve as the potential biomarkers for accurately predicting whether the disease will spread. Their study is in ACS' Journal of Proteome Research, a monthly publication.

4 Mar 2010

New chemical classes of preclinical compounds identified for Alzheimer’s disease

In an announcement today, Mount Sinai School of Medicine and Medisyn Technologies, Inc. said they have identified new chemical classes of preclinical compounds that may eventually lead to the first effective management of toxic amyloid aggregation and accumulation in the brain— an abnormal biological process long suspected by many researchers to be a major culprit in the onset and progression of Alzheimer’s disease.

4 Mar 2010

Negative results from latrepirdine Phase III clinical trial: Alzheimer's Association disappointed

"The Alzheimer's Association is disappointed to learn of the negative results from the Phase III clinical trial of latrepirdine (Dimebon)," said William Thies, Ph.D., Alzheimer's Association Chief Medical and Scientific Officer. "People with Alzheimer's, their families and caregivers desperately need more and better treatment options for this devastating, fatal brain disease."

4 Mar 2010

Research explores the importance of patient's outlook on health behavior and health status

Research published in the March edition of the Journal of Thoracic Oncology explored the importance of a patient's outlook as it relates to health behavior and health status. Researchers focused on lung cancer patients and discovered that those who exhibited an optimistic disposition experienced more favorable outcomes than those with a pessimistic disposition.

4 Mar 2010

Beta blockers improve heart function; eliminate need for implantable cardiac devices

New Saint Louis University research has found that beta blockers, a class of drugs used to prevent the progression of heart failure and manage arrhythmias (irregular heart beat) and hypertension (high blood pressure), are underused in heart failure patients who receive implantable cardiac devices.

4 Mar 2010

Study indicates ocular shingles may increase stroke risk

Having a shingles infection that affects the eyes may increase the risk of stroke, according to new research published in the March 3, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

4 Mar 2010

Patients with confirmed episodes of consciousness during surgery have high rates of PTSD: Study

Patients with confirmed episodes of consciousness during surgery have high rates of psychological problems including posttraumatic stress disorder (PTSD), even several years after the incident, reports a study in the March issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

4 Mar 2010

Prolonged use of HRT may increase risk of lung cancer

Women aged 50 to 76 who take estrogen plus progestin may have an increased risk of lung cancer, according to a new study published in the pre-print online edition of the Journal of Clinical Oncology.

4 Mar 2010

Researchers launch new project to diagnose and treat dementia among Deaf people who use BSL

Researchers have launched a unique project to improve early diagnosis and management of dementia among Deaf people who use British Sign Language (BSL).

From The University of Manchester 3 Mar 2010

Study finds early surgical treatment may benefit people who suffer from biceps injuries

People who suffer from injuries to the distal biceps tendon may benefit from earlier surgical intervention and new surgical techniques, according to a review article published in the March 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS).

3 Mar 2010

Shock: Norepinephrine favored over dopamine

Physicians treating patients with shock should consider norepinephrine instead of dopamine as a tool for stabilizing blood pressure, according to an editorial in the March 4, 2010, issue of the New England Journal of Medicine (NEJM).

3 Mar 2010

AGN-209323 small molecule for neuropathic pain: Bristol-Myers Squibb, Allergan announce global agreement

Bristol-Myers Squibb Company and Allergan, Inc. today announced a global agreement for the development and commercialization of AGN-209323, a Phase II-ready, orally administered small molecule in clinical development for neuropathic pain.

3 Mar 2010

Actemra: 38% of rheumatologists have commenced treatment

BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1 today, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in late February.

3 Mar 2010

Pfizer, Medivation announce results of two dimebon Phase 3 trials in AD patients

Pfizer Inc. and Medivation, Inc. today announced results from two Phase 3 trials of the investigational drug dimebon (latrepirdine) in patients with Alzheimer’s disease (AD). In the CONNECTION trial, dimebon did not meet its co-primary or secondary efficacy endpoints compared to placebo. Co-primary endpoints were measures of cognition and global function.

3 Mar 2010

Spectral Diagnostics receives FDA IDE approval for Toraymyxin

BioMS Medical Corp. today reported that Spectral Diagnostics has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Toraymyxin(TM). Spectral Diagnostics and BioMS have entered into a services agreement whereby BioMS will assist Spectral, as required, in its commercialization of Toraymyxin(TM), a therapeutic hemoperfusion device for the treatment of severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States.

3 Mar 2010

Gene 'addiction' of leukaemia cells

An international team of scientists studying acute forms of Leukaemia have identified a new drug target to inhibit the genes which are vital for the growth of diseased cells. The research, reported in EMBO Molecular Medicine, reveals how leukaemia cells become 'addicted' to genes, which if targeted could prevent diseased cells from developing.

3 Mar 2010

Pennsylvania makes available $400,000 in federal fund to support individuals within criminal justice system

Pennsylvania is making available $400,000 in federal American Recovery and Reinvestment Act funds to provide certified forensic peer support services to individuals within the criminal justice system who are suffering from mental illness, as well as psychiatric and substance abuse disorders.

3 Mar 2010

Allergan celebrates 20th anniversary of BOTOX in Canada

Twenty years ago, the first approved use of BOTOX(R) (botulinum toxin type A), a neurotoxin widely used to treat several life altering medical conditions, was granted in Canada. As part of the 20th anniversary celebrations, healthcare professionals from coast to coast reflect upon the discovery, science and evolution of a therapy that has impacted the lives of millions of patients worldwide.

3 Mar 2010

Seattle Genetics generates $110M through ADC technology license agreements

Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Genentech, Inc., a wholly owned member of the Roche Group.

3 Mar 2010

Medical Condition News

Community support critical for reducing childhood obesity

Scientists identify two proteins that serve as biomarkers for tracking the spread of colon cancer

New chemical classes of preclinical compounds identified for Alzheimer’s disease

Negative results from latrepirdine Phase III clinical trial: Alzheimer's Association disappointed

Research explores the importance of patient's outlook on health behavior and health status

Beta blockers improve heart function; eliminate need for implantable cardiac devices

Study indicates ocular shingles may increase stroke risk

Patients with confirmed episodes of consciousness during surgery have high rates of PTSD: Study

Prolonged use of HRT may increase risk of lung cancer

Researchers launch new project to diagnose and treat dementia among Deaf people who use BSL

Study finds early surgical treatment may benefit people who suffer from biceps injuries

Shock: Norepinephrine favored over dopamine

AGN-209323 small molecule for neuropathic pain: Bristol-Myers Squibb, Allergan announce global agreement

Actemra: 38% of rheumatologists have commenced treatment

Pfizer, Medivation announce results of two dimebon Phase 3 trials in AD patients

Spectral Diagnostics receives FDA IDE approval for Toraymyxin

Gene 'addiction' of leukaemia cells

Pennsylvania makes available $400,000 in federal fund to support individuals within criminal justice system

Allergan celebrates 20th anniversary of BOTOX in Canada

Seattle Genetics generates $110M through ADC technology license agreements

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Latest News